Global Oral Vaccines Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Oral Vaccines market size is predicted to grow from US$ 2631 million in 2025 to US$ 3419 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.
LP Information, Inc. (LPI) ' newest research report, the “Oral Vaccines Industry Forecast” looks at past sales and reviews total world Oral Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Vaccines sales for 2025 through 2031. With Oral Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Oral Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Oral Vaccines market?
What factors are driving Oral Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Vaccines market opportunities vary by end market size?
How does Oral Vaccines break out by Type, by Application?
The global Oral Vaccines market size is predicted to grow from US$ 2631 million in 2025 to US$ 3419 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.
LP Information, Inc. (LPI) ' newest research report, the “Oral Vaccines Industry Forecast” looks at past sales and reviews total world Oral Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Vaccines sales for 2025 through 2031. With Oral Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Oral Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
- Public
- Private
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
What is the 10-year outlook for the global Oral Vaccines market?
What factors are driving Oral Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Vaccines market opportunities vary by end market size?
How does Oral Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Oral Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Oral Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Oral Vaccines Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 Oral Polio Vaccine
2.3 Oral Vaccines Sales by Type
2.3.1 Global Oral Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Oral Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Oral Vaccines Sale Price by Type (2020-2025)
2.4 Oral Vaccines Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Oral Vaccines Sales by Application
2.5.1 Global Oral Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Oral Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Oral Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Oral Vaccines Breakdown Data by Company
3.1.1 Global Oral Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Oral Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Oral Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Oral Vaccines Revenue by Company (2020-2025)
3.2.2 Global Oral Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Oral Vaccines Sale Price by Company
3.4 Key Manufacturers Oral Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Vaccines Product Location Distribution
3.4.2 Players Oral Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Oral Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Oral Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Oral Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oral Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Oral Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Oral Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oral Vaccines Sales Growth
4.4 APAC Oral Vaccines Sales Growth
4.5 Europe Oral Vaccines Sales Growth
4.6 Middle East & Africa Oral Vaccines Sales Growth
5 AMERICAS
5.1 Americas Oral Vaccines Sales by Country
5.1.1 Americas Oral Vaccines Sales by Country (2020-2025)
5.1.2 Americas Oral Vaccines Revenue by Country (2020-2025)
5.2 Americas Oral Vaccines Sales by Type (2020-2025)
5.3 Americas Oral Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Vaccines Sales by Region
6.1.1 APAC Oral Vaccines Sales by Region (2020-2025)
6.1.2 APAC Oral Vaccines Revenue by Region (2020-2025)
6.2 APAC Oral Vaccines Sales by Type (2020-2025)
6.3 APAC Oral Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Vaccines by Country
7.1.1 Europe Oral Vaccines Sales by Country (2020-2025)
7.1.2 Europe Oral Vaccines Revenue by Country (2020-2025)
7.2 Europe Oral Vaccines Sales by Type (2020-2025)
7.3 Europe Oral Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Vaccines by Country
8.1.1 Middle East & Africa Oral Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Oral Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Oral Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Oral Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Vaccines
10.3 Manufacturing Process Analysis of Oral Vaccines
10.4 Industry Chain Structure of Oral Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Vaccines Distributors
11.3 Oral Vaccines Customer
12 WORLD FORECAST REVIEW FOR ORAL VACCINES BY GEOGRAPHIC REGION
12.1 Global Oral Vaccines Market Size Forecast by Region
12.1.1 Global Oral Vaccines Forecast by Region (2026-2031)
12.1.2 Global Oral Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oral Vaccines Forecast by Type (2026-2031)
12.7 Global Oral Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Oral Vaccines Product Portfolios and Specifications
13.1.3 Merck Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Oral Vaccines Product Portfolios and Specifications
13.2.3 GSK Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Oral Vaccines Product Portfolios and Specifications
13.3.3 Sanofi Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Lanzhou Institute
13.4.1 Lanzhou Institute Company Information
13.4.2 Lanzhou Institute Oral Vaccines Product Portfolios and Specifications
13.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Lanzhou Institute Main Business Overview
13.4.5 Lanzhou Institute Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute Oral Vaccines Product Portfolios and Specifications
13.5.3 Serum Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 Valneva
13.6.1 Valneva Company Information
13.6.2 Valneva Oral Vaccines Product Portfolios and Specifications
13.6.3 Valneva Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Valneva Main Business Overview
13.6.5 Valneva Latest Developments
13.7 Shanghai United Cell
13.7.1 Shanghai United Cell Company Information
13.7.2 Shanghai United Cell Oral Vaccines Product Portfolios and Specifications
13.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shanghai United Cell Main Business Overview
13.7.5 Shanghai United Cell Latest Developments
13.8 Bibcol
13.8.1 Bibcol Company Information
13.8.2 Bibcol Oral Vaccines Product Portfolios and Specifications
13.8.3 Bibcol Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bibcol Main Business Overview
13.8.5 Bibcol Latest Developments
13.9 PaxVax
13.9.1 PaxVax Company Information
13.9.2 PaxVax Oral Vaccines Product Portfolios and Specifications
13.9.3 PaxVax Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 PaxVax Main Business Overview
13.9.5 PaxVax Latest Developments
13.10 Vabiotech
13.10.1 Vabiotech Company Information
13.10.2 Vabiotech Oral Vaccines Product Portfolios and Specifications
13.10.3 Vabiotech Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Vabiotech Main Business Overview
13.10.5 Vabiotech Latest Developments
13.11 Tiantan Biological
13.11.1 Tiantan Biological Company Information
13.11.2 Tiantan Biological Oral Vaccines Product Portfolios and Specifications
13.11.3 Tiantan Biological Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Tiantan Biological Main Business Overview
13.11.5 Tiantan Biological Latest Developments
13.12 EuBiologics
13.12.1 EuBiologics Company Information
13.12.2 EuBiologics Oral Vaccines Product Portfolios and Specifications
13.12.3 EuBiologics Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 EuBiologics Main Business Overview
13.12.5 EuBiologics Latest Developments
13.13 Panacea Biotec Ltd
13.13.1 Panacea Biotec Ltd Company Information
13.13.2 Panacea Biotec Ltd Oral Vaccines Product Portfolios and Specifications
13.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Panacea Biotec Ltd Main Business Overview
13.13.5 Panacea Biotec Ltd Latest Developments
13.14 Bio-Med
13.14.1 Bio-Med Company Information
13.14.2 Bio-Med Oral Vaccines Product Portfolios and Specifications
13.14.3 Bio-Med Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Bio-Med Main Business Overview
13.14.5 Bio-Med Latest Developments
13.15 Halfkin Bio-Pharmaceuticals
13.15.1 Halfkin Bio-Pharmaceuticals Company Information
13.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolios and Specifications
13.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Oral Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Oral Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Rotavirus Vaccine
Table 4. Major Players of Cholera Vaccine
Table 5. Major Players of Oral Polio Vaccine
Table 6. Global Oral Vaccines Sales byType (2020-2025) & (K Units)
Table 7. Global Oral Vaccines Sales Market Share byType (2020-2025)
Table 8. Global Oral Vaccines Revenue byType (2020-2025) & ($ million)
Table 9. Global Oral Vaccines Revenue Market Share byType (2020-2025)
Table 10. Global Oral Vaccines Sale Price byType (2020-2025) & (USD/Unit)
Table 11. Global Oral Vaccines Sale by Application (2020-2025) & (K Units)
Table 12. Global Oral Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global Oral Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global Oral Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global Oral Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Oral Vaccines Sales by Company (2020-2025) & (K Units)
Table 17. Global Oral Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global Oral Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Oral Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global Oral Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Oral Vaccines Producing Area Distribution and Sales Area
Table 22. Players Oral Vaccines Products Offered
Table 23. Oral Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Oral Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Oral Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global Oral Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Oral Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Oral Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Oral Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global Oral Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Oral Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Oral Vaccines Sales by Country (2020-2025) & (K Units)
Table 35. Americas Oral Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas Oral Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Oral Vaccines Sales byType (2020-2025) & (K Units)
Table 38. Americas Oral Vaccines Sales by Application (2020-2025) & (K Units)
Table 39. APAC Oral Vaccines Sales by Region (2020-2025) & (K Units)
Table 40. APAC Oral Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC Oral Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Oral Vaccines Sales byType (2020-2025) & (K Units)
Table 43. APAC Oral Vaccines Sales by Application (2020-2025) & (K Units)
Table 44. Europe Oral Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. Europe Oral Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Oral Vaccines Sales byType (2020-2025) & (K Units)
Table 47. Europe Oral Vaccines Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Oral Vaccines Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Oral Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Oral Vaccines Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Oral Vaccines Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Oral Vaccines
Table 53. Key Market Challenges & Risks of Oral Vaccines
Table 54. Key IndustryTrends of Oral Vaccines
Table 55. Oral Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Oral Vaccines Distributors List
Table 58. Oral Vaccines Customer List
Table 59. Global Oral Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Oral Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Oral Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Oral Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Oral Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Oral Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Oral Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Oral Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Oral Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Oral Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Oral Vaccines SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Oral Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Oral Vaccines SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Oral Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Merck Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Oral Vaccines Product Portfolios and Specifications
Table 75. Merck Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. GSK Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Oral Vaccines Product Portfolios and Specifications
Table 80. GSK Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Sanofi Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Oral Vaccines Product Portfolios and Specifications
Table 85. Sanofi Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Lanzhou Institute Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Lanzhou Institute Oral Vaccines Product Portfolios and Specifications
Table 90. Lanzhou Institute Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Lanzhou Institute Main Business
Table 92. Lanzhou Institute Latest Developments
Table 93. Serum Institute Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Serum Institute Oral Vaccines Product Portfolios and Specifications
Table 95. Serum Institute Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Serum Institute Main Business
Table 97. Serum Institute Latest Developments
Table 98. Valneva Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Valneva Oral Vaccines Product Portfolios and Specifications
Table 100. Valneva Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Valneva Main Business
Table 102. Valneva Latest Developments
Table 103. Shanghai United Cell Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Shanghai United Cell Oral Vaccines Product Portfolios and Specifications
Table 105. Shanghai United Cell Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Shanghai United Cell Main Business
Table 107. Shanghai United Cell Latest Developments
Table 108. Bibcol Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Bibcol Oral Vaccines Product Portfolios and Specifications
Table 110. Bibcol Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Bibcol Main Business
Table 112. Bibcol Latest Developments
Table 113. PaxVax Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. PaxVax Oral Vaccines Product Portfolios and Specifications
Table 115. PaxVax Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. PaxVax Main Business
Table 117. PaxVax Latest Developments
Table 118. Vabiotech Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Vabiotech Oral Vaccines Product Portfolios and Specifications
Table 120. Vabiotech Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Vabiotech Main Business
Table 122. Vabiotech Latest Developments
Table 123.Tiantan Biological Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124.Tiantan Biological Oral Vaccines Product Portfolios and Specifications
Table 125.Tiantan Biological Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126.Tiantan Biological Main Business
Table 127.Tiantan Biological Latest Developments
Table 128. EuBiologics Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. EuBiologics Oral Vaccines Product Portfolios and Specifications
Table 130. EuBiologics Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. EuBiologics Main Business
Table 132. EuBiologics Latest Developments
Table 133. Panacea Biotec Ltd Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Panacea Biotec Ltd Oral Vaccines Product Portfolios and Specifications
Table 135. Panacea Biotec Ltd Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Panacea Biotec Ltd Main Business
Table 137. Panacea Biotec Ltd Latest Developments
Table 138. Bio-Med Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Bio-Med Oral Vaccines Product Portfolios and Specifications
Table 140. Bio-Med Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Bio-Med Main Business
Table 142. Bio-Med Latest Developments
Table 143. Halfkin Bio-Pharmaceuticals Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolios and Specifications
Table 145. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 146. Halfkin Bio-Pharmaceuticals Main Business
Table 147. Halfkin Bio-Pharmaceuticals Latest Developments
LIST OFFIGURES
Figure 1. Picture of Oral Vaccines
Figure 2. Oral Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Oral Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Oral Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Oral Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Oral Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Rotavirus Vaccine
Figure 12. Product Picture of Cholera Vaccine
Figure 13. Product Picture of Oral Polio Vaccine
Figure 14. Global Oral Vaccines Sales Market Share byType in 2025
Figure 15. Global Oral Vaccines Revenue Market Share byType (2020-2025)
Figure 16. Oral Vaccines Consumed in Public
Figure 17. Global Oral Vaccines Market: Public (2020-2025) & (K Units)
Figure 18. Oral Vaccines Consumed in Private
Figure 19. Global Oral Vaccines Market: Private (2020-2025) & (K Units)
Figure 20. Global Oral Vaccines Sale Market Share by Application (2024)
Figure 21. Global Oral Vaccines Revenue Market Share by Application in 2025
Figure 22. Oral Vaccines Sales by Company in 2025 (K Units)
Figure 23. Global Oral Vaccines Sales Market Share by Company in 2025
Figure 24. Oral Vaccines Revenue by Company in 2025 ($ millions)
Figure 25. Global Oral Vaccines Revenue Market Share by Company in 2025
Figure 26. Global Oral Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Oral Vaccines Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Oral Vaccines Sales 2020-2025 (K Units)
Figure 29. Americas Oral Vaccines Revenue 2020-2025 ($ millions)
Figure 30. APAC Oral Vaccines Sales 2020-2025 (K Units)
Figure 31. APAC Oral Vaccines Revenue 2020-2025 ($ millions)
Figure 32. Europe Oral Vaccines Sales 2020-2025 (K Units)
Figure 33. Europe Oral Vaccines Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Oral Vaccines Sales 2020-2025 (K Units)
Figure 35. Middle East & Africa Oral Vaccines Revenue 2020-2025 ($ millions)
Figure 36. Americas Oral Vaccines Sales Market Share by Country in 2025
Figure 37. Americas Oral Vaccines Revenue Market Share by Country (2020-2025)
Figure 38. Americas Oral Vaccines Sales Market Share byType (2020-2025)
Figure 39. Americas Oral Vaccines Sales Market Share by Application (2020-2025)
Figure 40. United States Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Oral Vaccines Sales Market Share by Region in 2025
Figure 45. APAC Oral Vaccines Revenue Market Share by Region (2020-2025)
Figure 46. APAC Oral Vaccines Sales Market Share byType (2020-2025)
Figure 47. APAC Oral Vaccines Sales Market Share by Application (2020-2025)
Figure 48. China Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. India Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. ChinaTaiwan Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Oral Vaccines Sales Market Share by Country in 2025
Figure 56. Europe Oral Vaccines Revenue Market Share by Country (2020-2025)
Figure 57. Europe Oral Vaccines Sales Market Share byType (2020-2025)
Figure 58. Europe Oral Vaccines Sales Market Share by Application (2020-2025)
Figure 59. Germany Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60.France Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Oral Vaccines Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Oral Vaccines Sales Market Share byType (2020-2025)
Figure 66. Middle East & Africa Oral Vaccines Sales Market Share by Application (2020-2025)
Figure 67. Egypt Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70.Turkey Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Oral Vaccines in 2025
Figure 73. Manufacturing Process Analysis of Oral Vaccines
Figure 74. Industry Chain Structure of Oral Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Oral Vaccines Sales MarketForecast by Region (2026-2031)
Figure 77. Global Oral Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 78. Global Oral Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 79. Global Oral Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 80. Global Oral Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 81. Global Oral Vaccines Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oral Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Oral Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Oral Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Oral Vaccines Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 Oral Polio Vaccine
2.3 Oral Vaccines Sales by Type
2.3.1 Global Oral Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Oral Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Oral Vaccines Sale Price by Type (2020-2025)
2.4 Oral Vaccines Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Oral Vaccines Sales by Application
2.5.1 Global Oral Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Oral Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Oral Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Oral Vaccines Breakdown Data by Company
3.1.1 Global Oral Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Oral Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Oral Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Oral Vaccines Revenue by Company (2020-2025)
3.2.2 Global Oral Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Oral Vaccines Sale Price by Company
3.4 Key Manufacturers Oral Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Vaccines Product Location Distribution
3.4.2 Players Oral Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ORAL VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Oral Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Oral Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Oral Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oral Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Oral Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Oral Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oral Vaccines Sales Growth
4.4 APAC Oral Vaccines Sales Growth
4.5 Europe Oral Vaccines Sales Growth
4.6 Middle East & Africa Oral Vaccines Sales Growth
5 AMERICAS
5.1 Americas Oral Vaccines Sales by Country
5.1.1 Americas Oral Vaccines Sales by Country (2020-2025)
5.1.2 Americas Oral Vaccines Revenue by Country (2020-2025)
5.2 Americas Oral Vaccines Sales by Type (2020-2025)
5.3 Americas Oral Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Vaccines Sales by Region
6.1.1 APAC Oral Vaccines Sales by Region (2020-2025)
6.1.2 APAC Oral Vaccines Revenue by Region (2020-2025)
6.2 APAC Oral Vaccines Sales by Type (2020-2025)
6.3 APAC Oral Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oral Vaccines by Country
7.1.1 Europe Oral Vaccines Sales by Country (2020-2025)
7.1.2 Europe Oral Vaccines Revenue by Country (2020-2025)
7.2 Europe Oral Vaccines Sales by Type (2020-2025)
7.3 Europe Oral Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oral Vaccines by Country
8.1.1 Middle East & Africa Oral Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Oral Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Oral Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Oral Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Vaccines
10.3 Manufacturing Process Analysis of Oral Vaccines
10.4 Industry Chain Structure of Oral Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Vaccines Distributors
11.3 Oral Vaccines Customer
12 WORLD FORECAST REVIEW FOR ORAL VACCINES BY GEOGRAPHIC REGION
12.1 Global Oral Vaccines Market Size Forecast by Region
12.1.1 Global Oral Vaccines Forecast by Region (2026-2031)
12.1.2 Global Oral Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oral Vaccines Forecast by Type (2026-2031)
12.7 Global Oral Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Oral Vaccines Product Portfolios and Specifications
13.1.3 Merck Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Oral Vaccines Product Portfolios and Specifications
13.2.3 GSK Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Oral Vaccines Product Portfolios and Specifications
13.3.3 Sanofi Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Lanzhou Institute
13.4.1 Lanzhou Institute Company Information
13.4.2 Lanzhou Institute Oral Vaccines Product Portfolios and Specifications
13.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Lanzhou Institute Main Business Overview
13.4.5 Lanzhou Institute Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute Oral Vaccines Product Portfolios and Specifications
13.5.3 Serum Institute Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 Valneva
13.6.1 Valneva Company Information
13.6.2 Valneva Oral Vaccines Product Portfolios and Specifications
13.6.3 Valneva Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Valneva Main Business Overview
13.6.5 Valneva Latest Developments
13.7 Shanghai United Cell
13.7.1 Shanghai United Cell Company Information
13.7.2 Shanghai United Cell Oral Vaccines Product Portfolios and Specifications
13.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Shanghai United Cell Main Business Overview
13.7.5 Shanghai United Cell Latest Developments
13.8 Bibcol
13.8.1 Bibcol Company Information
13.8.2 Bibcol Oral Vaccines Product Portfolios and Specifications
13.8.3 Bibcol Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bibcol Main Business Overview
13.8.5 Bibcol Latest Developments
13.9 PaxVax
13.9.1 PaxVax Company Information
13.9.2 PaxVax Oral Vaccines Product Portfolios and Specifications
13.9.3 PaxVax Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 PaxVax Main Business Overview
13.9.5 PaxVax Latest Developments
13.10 Vabiotech
13.10.1 Vabiotech Company Information
13.10.2 Vabiotech Oral Vaccines Product Portfolios and Specifications
13.10.3 Vabiotech Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Vabiotech Main Business Overview
13.10.5 Vabiotech Latest Developments
13.11 Tiantan Biological
13.11.1 Tiantan Biological Company Information
13.11.2 Tiantan Biological Oral Vaccines Product Portfolios and Specifications
13.11.3 Tiantan Biological Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Tiantan Biological Main Business Overview
13.11.5 Tiantan Biological Latest Developments
13.12 EuBiologics
13.12.1 EuBiologics Company Information
13.12.2 EuBiologics Oral Vaccines Product Portfolios and Specifications
13.12.3 EuBiologics Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 EuBiologics Main Business Overview
13.12.5 EuBiologics Latest Developments
13.13 Panacea Biotec Ltd
13.13.1 Panacea Biotec Ltd Company Information
13.13.2 Panacea Biotec Ltd Oral Vaccines Product Portfolios and Specifications
13.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Panacea Biotec Ltd Main Business Overview
13.13.5 Panacea Biotec Ltd Latest Developments
13.14 Bio-Med
13.14.1 Bio-Med Company Information
13.14.2 Bio-Med Oral Vaccines Product Portfolios and Specifications
13.14.3 Bio-Med Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Bio-Med Main Business Overview
13.14.5 Bio-Med Latest Developments
13.15 Halfkin Bio-Pharmaceuticals
13.15.1 Halfkin Bio-Pharmaceuticals Company Information
13.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolios and Specifications
13.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Oral Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Oral Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Rotavirus Vaccine
Table 4. Major Players of Cholera Vaccine
Table 5. Major Players of Oral Polio Vaccine
Table 6. Global Oral Vaccines Sales byType (2020-2025) & (K Units)
Table 7. Global Oral Vaccines Sales Market Share byType (2020-2025)
Table 8. Global Oral Vaccines Revenue byType (2020-2025) & ($ million)
Table 9. Global Oral Vaccines Revenue Market Share byType (2020-2025)
Table 10. Global Oral Vaccines Sale Price byType (2020-2025) & (USD/Unit)
Table 11. Global Oral Vaccines Sale by Application (2020-2025) & (K Units)
Table 12. Global Oral Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global Oral Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global Oral Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global Oral Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Oral Vaccines Sales by Company (2020-2025) & (K Units)
Table 17. Global Oral Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global Oral Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Oral Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global Oral Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Oral Vaccines Producing Area Distribution and Sales Area
Table 22. Players Oral Vaccines Products Offered
Table 23. Oral Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Oral Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Oral Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global Oral Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Oral Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Oral Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Oral Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global Oral Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Oral Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Oral Vaccines Sales by Country (2020-2025) & (K Units)
Table 35. Americas Oral Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas Oral Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Oral Vaccines Sales byType (2020-2025) & (K Units)
Table 38. Americas Oral Vaccines Sales by Application (2020-2025) & (K Units)
Table 39. APAC Oral Vaccines Sales by Region (2020-2025) & (K Units)
Table 40. APAC Oral Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC Oral Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Oral Vaccines Sales byType (2020-2025) & (K Units)
Table 43. APAC Oral Vaccines Sales by Application (2020-2025) & (K Units)
Table 44. Europe Oral Vaccines Sales by Country (2020-2025) & (K Units)
Table 45. Europe Oral Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Oral Vaccines Sales byType (2020-2025) & (K Units)
Table 47. Europe Oral Vaccines Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Oral Vaccines Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Oral Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Oral Vaccines Sales byType (2020-2025) & (K Units)
Table 51. Middle East & Africa Oral Vaccines Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Oral Vaccines
Table 53. Key Market Challenges & Risks of Oral Vaccines
Table 54. Key IndustryTrends of Oral Vaccines
Table 55. Oral Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Oral Vaccines Distributors List
Table 58. Oral Vaccines Customer List
Table 59. Global Oral Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 60. Global Oral Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 61. Americas Oral Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 62. Americas Oral Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 63. APAC Oral Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 64. APAC Oral Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 65. Europe Oral Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 66. Europe Oral Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Oral Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Oral Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Global Oral Vaccines SalesForecast byType (2026-2031) & (K Units)
Table 70. Global Oral Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 71. Global Oral Vaccines SalesForecast by Application (2026-2031) & (K Units)
Table 72. Global Oral Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 73. Merck Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Oral Vaccines Product Portfolios and Specifications
Table 75. Merck Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. GSK Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Oral Vaccines Product Portfolios and Specifications
Table 80. GSK Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Sanofi Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Oral Vaccines Product Portfolios and Specifications
Table 85. Sanofi Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Lanzhou Institute Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Lanzhou Institute Oral Vaccines Product Portfolios and Specifications
Table 90. Lanzhou Institute Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Lanzhou Institute Main Business
Table 92. Lanzhou Institute Latest Developments
Table 93. Serum Institute Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Serum Institute Oral Vaccines Product Portfolios and Specifications
Table 95. Serum Institute Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Serum Institute Main Business
Table 97. Serum Institute Latest Developments
Table 98. Valneva Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Valneva Oral Vaccines Product Portfolios and Specifications
Table 100. Valneva Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Valneva Main Business
Table 102. Valneva Latest Developments
Table 103. Shanghai United Cell Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Shanghai United Cell Oral Vaccines Product Portfolios and Specifications
Table 105. Shanghai United Cell Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Shanghai United Cell Main Business
Table 107. Shanghai United Cell Latest Developments
Table 108. Bibcol Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Bibcol Oral Vaccines Product Portfolios and Specifications
Table 110. Bibcol Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Bibcol Main Business
Table 112. Bibcol Latest Developments
Table 113. PaxVax Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. PaxVax Oral Vaccines Product Portfolios and Specifications
Table 115. PaxVax Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. PaxVax Main Business
Table 117. PaxVax Latest Developments
Table 118. Vabiotech Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Vabiotech Oral Vaccines Product Portfolios and Specifications
Table 120. Vabiotech Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Vabiotech Main Business
Table 122. Vabiotech Latest Developments
Table 123.Tiantan Biological Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124.Tiantan Biological Oral Vaccines Product Portfolios and Specifications
Table 125.Tiantan Biological Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126.Tiantan Biological Main Business
Table 127.Tiantan Biological Latest Developments
Table 128. EuBiologics Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. EuBiologics Oral Vaccines Product Portfolios and Specifications
Table 130. EuBiologics Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. EuBiologics Main Business
Table 132. EuBiologics Latest Developments
Table 133. Panacea Biotec Ltd Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Panacea Biotec Ltd Oral Vaccines Product Portfolios and Specifications
Table 135. Panacea Biotec Ltd Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Panacea Biotec Ltd Main Business
Table 137. Panacea Biotec Ltd Latest Developments
Table 138. Bio-Med Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Bio-Med Oral Vaccines Product Portfolios and Specifications
Table 140. Bio-Med Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Bio-Med Main Business
Table 142. Bio-Med Latest Developments
Table 143. Halfkin Bio-Pharmaceuticals Basic Information, Oral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolios and Specifications
Table 145. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 146. Halfkin Bio-Pharmaceuticals Main Business
Table 147. Halfkin Bio-Pharmaceuticals Latest Developments
LIST OFFIGURES
Figure 1. Picture of Oral Vaccines
Figure 2. Oral Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Oral Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Oral Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Oral Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Oral Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Rotavirus Vaccine
Figure 12. Product Picture of Cholera Vaccine
Figure 13. Product Picture of Oral Polio Vaccine
Figure 14. Global Oral Vaccines Sales Market Share byType in 2025
Figure 15. Global Oral Vaccines Revenue Market Share byType (2020-2025)
Figure 16. Oral Vaccines Consumed in Public
Figure 17. Global Oral Vaccines Market: Public (2020-2025) & (K Units)
Figure 18. Oral Vaccines Consumed in Private
Figure 19. Global Oral Vaccines Market: Private (2020-2025) & (K Units)
Figure 20. Global Oral Vaccines Sale Market Share by Application (2024)
Figure 21. Global Oral Vaccines Revenue Market Share by Application in 2025
Figure 22. Oral Vaccines Sales by Company in 2025 (K Units)
Figure 23. Global Oral Vaccines Sales Market Share by Company in 2025
Figure 24. Oral Vaccines Revenue by Company in 2025 ($ millions)
Figure 25. Global Oral Vaccines Revenue Market Share by Company in 2025
Figure 26. Global Oral Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Oral Vaccines Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Oral Vaccines Sales 2020-2025 (K Units)
Figure 29. Americas Oral Vaccines Revenue 2020-2025 ($ millions)
Figure 30. APAC Oral Vaccines Sales 2020-2025 (K Units)
Figure 31. APAC Oral Vaccines Revenue 2020-2025 ($ millions)
Figure 32. Europe Oral Vaccines Sales 2020-2025 (K Units)
Figure 33. Europe Oral Vaccines Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Oral Vaccines Sales 2020-2025 (K Units)
Figure 35. Middle East & Africa Oral Vaccines Revenue 2020-2025 ($ millions)
Figure 36. Americas Oral Vaccines Sales Market Share by Country in 2025
Figure 37. Americas Oral Vaccines Revenue Market Share by Country (2020-2025)
Figure 38. Americas Oral Vaccines Sales Market Share byType (2020-2025)
Figure 39. Americas Oral Vaccines Sales Market Share by Application (2020-2025)
Figure 40. United States Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Oral Vaccines Sales Market Share by Region in 2025
Figure 45. APAC Oral Vaccines Revenue Market Share by Region (2020-2025)
Figure 46. APAC Oral Vaccines Sales Market Share byType (2020-2025)
Figure 47. APAC Oral Vaccines Sales Market Share by Application (2020-2025)
Figure 48. China Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. India Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. ChinaTaiwan Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Oral Vaccines Sales Market Share by Country in 2025
Figure 56. Europe Oral Vaccines Revenue Market Share by Country (2020-2025)
Figure 57. Europe Oral Vaccines Sales Market Share byType (2020-2025)
Figure 58. Europe Oral Vaccines Sales Market Share by Application (2020-2025)
Figure 59. Germany Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60.France Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Oral Vaccines Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Oral Vaccines Sales Market Share byType (2020-2025)
Figure 66. Middle East & Africa Oral Vaccines Sales Market Share by Application (2020-2025)
Figure 67. Egypt Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70.Turkey Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Oral Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Oral Vaccines in 2025
Figure 73. Manufacturing Process Analysis of Oral Vaccines
Figure 74. Industry Chain Structure of Oral Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Oral Vaccines Sales MarketForecast by Region (2026-2031)
Figure 77. Global Oral Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 78. Global Oral Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 79. Global Oral Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 80. Global Oral Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 81. Global Oral Vaccines Revenue Market ShareForecast by Application (2026-2031)
